A study of drugs given in hypertension and evaluation of cardiovascular risk in hypertensive post-menopausal wome
- Conditions
- Health Condition 1: null- HYPERTENSIO
- Registration Number
- CTRI/2017/06/008779
- Lead Sponsor
- Govt Medical College Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1 Women with self reported cessation of menstruation for more than 12 consecutive months.
2PMW with surgically induced menopause.
3Patients with HT in stage I/ stage II.
4Newly diagnosed and old patients of HT.
5Hypertensive patients with or without comorbidities like diabetes, obesity, hypothyroidism.
Exclusion Criteria
1Women with indeterminate menopausal status.
2Patients with SBP > 210 and/or DBP > 120 mm Hg, requiring emergency care.
3Patients with CAD at present or previous history of CAD.
4Patients with chronic renal or hepatic disease.
•Women with indeterminate menopausal status.
•Patients with SBP > 210 and/or DBP > 120 mm Hg, requiring emergency care.
•Patients with CAD at present or previous history of CAD.
•Patients with chronic renal or hepatic disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the prescription trends of anti-hypertensive drugs in PMW.Timepoint: Single observation at the time of inclusion in the study
- Secondary Outcome Measures
Name Time Method Evaluate the 10 year cardiovascular risk in PMW so that high risk PMW can be identified.Timepoint: Single observation at the time of inclusion in the study